Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 396 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Catalyst Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 360
- +1 vs. Q2 2025
- Shares held
- 103.3M
- +2.03M (+2.0%) vs. Q2 2025
- Total value
- $2.04B
- −$162.7M (−7.4%) vs. Q2 2025
- New holders
- 48
- 129 more added
- Sold out
- 47
- 135 more reduced
6 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 396 | $3.39B |
| Q1 2026 | 382 | $2.59B |
| Q4 2025 | 375 | $2.43B |
| Q3 2025 | 360 | $2.04B |
| Q2 2025 | 365 | $2.20B |
| Q1 2025 | 370 | $2.37B |
| Q4 2024 | 336 | $2.04B |
| Q3 2024 | 316 | $1.90B |
| Q2 2024 | 271 | $1.50B |
| Q1 2024 | 268 | $1.53B |
| Q4 2023 | 259 | $1.42B |
| Q3 2023 | 256 | $948.8M |
| Q2 2023 | 248 | $1.11B |
| Q1 2023 | 260 | $1.47B |
| Q4 2022 | 257 | $1.56B |
| Q3 2022 | 229 | $1.09B |
| Q2 2022 | 190 | $531.7M |
| Q1 2022 | 186 | $585.5M |
| Q4 2021 | 164 | $446.7M |
| Q3 2021 | 144 | $345.1M |
| Q2 2021 | 139 | $376.6M |
| Q1 2021 | 133 | $312.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Catalyst Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| True Wealth Design, LLC | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Mark Sheptoff Financial Planning, LLC | 0 | $0 | 0.00% | −113−100.0% | Sold out |
| Park Square Financial Group, LLC | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Annis Gardner Whiting Capital Advisors, LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| ORG Partners LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Strengthening Families & Communities, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| EP Wealth Advisors, LLC | – | – | – | – | Not filed |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |
| First Horizon Advisors, Inc. | – | – | – | – | Not filed |
| Legacy Investment Solutions, LLC | – | – | – | – | Not filed |